Halozyme Therapeutics, Inc.
Halozyme Therapeutics, Inc.（HALO）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
halo · 股价预测 · 27 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 27 位华尔街分析师
Buy
27 位分析师
共识
评级分布
12 个月目标价
High
$95.00
Consensus
$88.25
+23.4% upside
Low
$75.00
Median: $91.5 · Last Close: $71.53
12 个月目标价预测
历史收盘价 + 分析师 12 个月目标价预测区间
Consensus Target
$88.25
23.4% upside
High Target
$95
32.8%
Low Target
$75
4.9%
Current Price
$71.53
as of today
Based on analyst price targets, the HALO stock price prediction for the next 12 months ranges from $75 to $95. The consensus HALO price forecast of $88.25 implies 23.4% upside from the current price of $71.53.
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-09 | $72.13 | ↑ 0.84% |
1-day model range: $71.84–$72.43. Peak: $72.43 (+0.84%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $108 | +50.5% |
| 2028 | $140 | +96.2% |
| 2029 | $166 | +131.9% |
| 2030 | $184 | +157.2% |
| 2031 | — | +174.0% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · HALO · Jun 8, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2026-05-12 | Morgan Stanley | Maintains | Overweight→Overweight |
| 2026-04-29 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2026-02-19 | Wells Fargo | Maintains | Equal Weight→Equal Weight |
| 2026-02-19 | Benchmark | Maintains | Buy→Buy |
| 2026-01-08 | TD Cowen | Maintains | Buy→Buy |
| 2025-12-19 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-11-18 | Goldman Sachs | Maintains | Neutral→Neutral |
| 2025-11-04 | Citizens | Maintains | Market Outperform→Market Outperform |
| 2025-10-27 | JP Morgan | Maintains | Neutral→Neutral |
Wall Street analysts have recently issued updated ratings on Halozyme Therapeutics, Inc. (HALO) stock. Of the recent 178 rating actions, 8 were upgrades and 13 were downgrades. 27 analysts currently cover HALO.
分析师推荐趋势
HALO analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$1.8B
↓ 18.6% YoY
Revenue Next Year
$2.0B
↑ 12.8% YoY
EPS This Year
$8.11
EPS Next Year
$9.93
↑ 22.4% YoY
EPS ForecastReported vs Estimated
Analysts forecast HALO EPS of $8.11 for the current fiscal year, based on estimates from 4 analysts. The HALO revenue forecast is $1.8B for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
HALO 股价预测由两类独立数据源支撑：来自 27 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。HALO 的共识目标价为 $88.25（+23.4% 上行空间），分析师共识为 Buy。
HALO 的短期预测（明日）为 $72.13（+0.84%）。 HALO 对 2027 年的股价预测均值为 $108。 HALO 对 2030 年的预测区间为 $176–$192。
Halozyme Therapeutics, Inc. 在 NASDAQ 上市，代码 HALO。HALO 在 2027 年的整体展望偏积极，在覆盖分析师中约 63% 对应 Buy 共识。
常见问题
HALO 预测 · 8 个问题根据 27 位华尔街分析师，HALO 的 12 个月平均目标价为 $88.25，最高 $95.00、最低 $75.00。若有图表，中位目标价可在上方查看。相对当前价 $71.53，隐含约 +23.4% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.